Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 10:23 am Sale | 2023-12-31 | 13G | Enzo Biochem, Inc. ENZ | 1 MAIN CAPITAL MANAGEMENT LLC | 2,500,000 4.950% | -374,125 (-13.02%) | Filing History |
| 2024-02-13 09:35 am Sale | 2023-12-29 | 13G | Enzo Biochem, Inc. ENZ | RENAISSANCE TECHNOLOGIES CORP | 2,479,195 4.910% | -334,769 (-11.90%) | Filing History |
| 2023-09-11 5:14 pm Purchase | 2023-09-01 | 13G | Enzo Biochem, Inc. ENZ | 1 MAIN CAPITAL MANAGEMENT LLC | 2,874,125 5.800% | 2,874,125 (New Position) | Filing History |
| 2023-07-24 4:20 pm Sale | 2023-07-24 | 13D | Enzo Biochem, Inc. ENZ | LABORATORY CORP OF AMERICA HOLDINGS LH | 0 0.000% | -4,862,730 (Position Closed) | Filing History |
| 2023-05-10 5:19 pm Purchase | 2023-03-16 | 13D | Enzo Biochem, Inc. ENZ | Radoff Bradley Louis | 4,605,132 9.300% | 307,032 (+7.14%) | Filing History |
| 2023-03-27 4:32 pm Purchase | 2023-03-16 | 13D | Enzo Biochem, Inc. ENZ | LABORATORY CORP OF AMERICA HOLDINGS LH | 4,862,730 9.800% | 4,862,730 (New Position) | Filing History |
| 2023-02-13 10:10 am Sale | 2022-12-30 | 13G | Enzo Biochem, Inc. ENZ | RENAISSANCE TECHNOLOGIES CORP | 2,813,964 5.780% | -280,800 (-9.07%) | Filing History |
| 2023-01-23 1:23 pm Purchase | 2022-11-23 | 13D | Enzo Biochem, Inc. ENZ | Wolf James G. | 4,942,400 10.140% | 773,900 (+18.57%) | Filing History |
| 2022-11-23 11:33 am Purchase | 2022-11-23 | 13D | Enzo Biochem, Inc. ENZ | Wolf James G. | 4,168,500 8.560% | 54,000 (+1.31%) | Filing History |
| 2022-10-26 1:07 pm Purchase | 2022-10-18 | 13D | Enzo Biochem, Inc. ENZ | Wolf James G. | 4,114,500 8.450% | 852,000 (+26.11%) | Filing History |
| 2022-03-24 5:50 pm Sale | 2022-03-21 | 13D | Enzo Biochem, Inc. ENZ | Roumell Asset Management LLC | 2,426,771 4.980% | -460,000 (-15.93%) | Filing History |
| 2022-02-14 10:49 am Sale | 2021-12-31 | 13G | Enzo Biochem, Inc. ENZ | RENAISSANCE TECHNOLOGIES CORP | 3,094,764 6.380% | -461,459 (-12.98%) | Filing History |
| 2022-02-10 08:11 am Sale | 2021-12-31 | 13G | Enzo Biochem, Inc. ENZ | VANGUARD GROUP INC | 1,783,048 3.680% | -614,750 (-25.64%) | Filing History |
| 2022-01-18 10:56 am Sale | 2021-12-31 | 13G | Enzo Biochem, Inc. ENZ | Evermore Global Advisors LLC | 0 0.000% | -2,605,607 (Position Closed) | Filing History |
| 2022-01-04 11:10 am Unchanged | 2022-01-03 | 13D | Enzo Biochem, Inc. ENZ | Radoff Bradley Louis | 4,298,100 8.900% | 0 (Unchanged) | Filing History |
| 2021-12-27 4:38 pm Purchase | 2021-12-03 | 13D | Enzo Biochem, Inc. ENZ | Radoff Bradley Louis | 4,298,100 8.900% | 683,100 (+18.90%) | Filing History |
| 2021-11-15 12:50 pm Purchase | 2021-10-15 | 13D | Enzo Biochem, Inc. ENZ | Wolf James G. | 3,262,500 6.730% | 621,800 (+23.55%) | Filing History |
| 2021-10-28 4:39 pm Unchanged | 2021-10-27 | 13D | Enzo Biochem, Inc. ENZ | HARBERT MICROCAP PARTNERS FUND LP | 5,175,913 10.680% | 0 (Unchanged) | Filing History |
| 2021-10-22 12:05 pm Purchase | 2021-10-20 | 13D | Enzo Biochem, Inc. ENZ | Radoff Bradley Louis | 3,615,000 7.500% | 505,000 (+16.24%) | Filing History |
| 2021-10-06 09:52 am Purchase | 2021-10-01 | 13D | Enzo Biochem, Inc. ENZ | Radoff Bradley Louis | 3,110,000 6.400% | 3,110,000 (New Position) | Filing History |